カート
レポートナンバー 0000034044
VPGMarketResearch
2023 U.K. Molecular Diagnostics Market: 2022 Supplier Shares, Instrumentation Installed Base and Strategies, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
発刊日 2023/01/23
言語英語
体裁PDF
ライセンス/価格
0000034044
※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。 ※本レポートは、英文です。電子媒体での納品となります。 ※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。
無料サンプル
このデータベースは、2022 年のサプライヤーのシェア、2022 年から 2027 年の感染症、遺伝子疾患、がん診断、法医学、および父子鑑定のアプリケーションに対する検査件数と売上予測、ならびに主要検査の新しい技術や製品を開発または販売している企業の包括的なリストを提供します。
調査範囲
List of Tables Major Companies Developing or Marketing AIDS Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Adenovirus Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Bartonella Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Candida Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Chlamydia Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Clostridium Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Coronavirus Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing CMV Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Echovirus Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Enterovirus Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing EBV Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Giardia Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Hantavirus Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Helicobacter Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Hepatitis Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Herpes Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Influenza Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Legionella Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Measles Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Meningitis Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Mumps Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Pneumonia Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing RSV Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Rotavirus Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Rubella Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Salmonella Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Septicemia Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Shigella Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Syphilis Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Trichomonas Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests Oncogenes Potential Application in Cancer Diagnosis Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases U.K. Molecular Diagnostics Test Volume And Sales By Major Application U.K. Laboratories Performing DNA Sequencing By Market Segment U.K. Molecular Diagnostics Market Potential Laboratory Universe by Market Segment U.K. Molecular Diagnostics Test Volume By Major Application U.K. Major Infectious Disease Test Volume by Assay U.K. Major Infectious Disease Test Volume by Method U.K. Molecular Diagnostics Market By Major Application U.K. Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers U.K. Major Infectious Disease Diagnostics Market by Assay U.K. AIDS Testing Market Estimated Sales by Major Supplier U.K. Gonorrhea Testing Market Estimated Sales by Major Supplier U.K. Hepatitis Testing Market Estimated Sales by Major Supplier U.K. Hepatitis C Testing Market Estimated Sales by Major Supplier U.K. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier U.K. Influenza Testing Market Estimated Sales by Major Supplier U.K. Mycoplasma Testing Market Estimated Sales by Major Supplier U.K. Pneumonia Testing Market Estimated Sales by Major Supplier U.K. Shigella Testing Market Estimated Sales by Major Supplier
この商品のレポートナンバー
2023 India Molecular Diagnostics Market: 2022 Supplier Shares, Instrumentation Installed Base and Strategies, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
2023/01/23
1,450 USD